[INFLUENCE OF SIMULTANEOUS ADMINISTRATION OF RESERPINE AND A CORTICOID ON CARCINOGENESIS OF RAT LIVER BY P-DIMETHYLAMINOAZOBENZENE (DAB)].
D002759:Adenoma, Bile Duct; D001650:Bile Duct Neoplasms; D001653:Bile Ducts, Intrahepatic; D063646:Carcinogenesis; D056486:Chemical and Drug Induced Liver Injury; D003900:Desoxycorticosterone; D005234:Fatty Liver; D006505:Hepatitis; D006854:Hydrocortisone; D008103:Liver Cirrhosis; D008106:Liver Cirrhosis, Experimental; D008113:Liver Neoplasms; D009374:Neoplasms, Experimental; D011488:Protein Deficiency; D051381:Rats; D012106:Research; D012110:Reserpine; D012257:Riboflavin Deficiency; D004124:p-Dimethylaminoazobenzene
D003900:Desoxycorticosterone; D012110:Reserpine; D004124:p-Dimethylaminoazobenzene; D006854:Hydrocortisone
CHOLANGIOMA; DESOXYCORTICOSTERONE; DIMETHYLAMINOAZOBENZENE; EXPERIMENTAL LAB STUDY; FATTY LIVER; HEPATITIS, TOXIC; HYDROCORTISONE; LIVER CIRRHOSIS, EXPERIMENTAL; LIVER NEOPLASMS; NEOPLASMS, EXPERIMENTAL; PROTEIN DEFICIENCY; RATS; RESERPINE; RIBOFLAVIN DEFICIENCY
INFLUENCE DE L'ADMINISTRATION SIMULTAN'EE DE R'ESERPINE ET D'UN CORTICOUIDE, SUR LA CANC'ERISATION DU FOIE DU RAT PAR LE P-DIM'ETHYLAMINOAZOBENZ'ENE (DAB)